Invion Ltd

AU:IVX Australia Drug Manufacturers - Specialty & Generic
Market Cap
$4.08 Million
AU$6.59 Million AUD
Market Cap Rank
#33639 Global
#1176 in Australia
Share Price
AU$0.08
Change (1 day)
+0.00%
52-Week Range
AU$0.08 - AU$0.15
All Time High
AU$4.80
About

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also in… Read more

Invion Ltd (IVX) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2025: -0.163x

Based on the latest financial reports, Invion Ltd (IVX) has a cash flow conversion efficiency ratio of -0.163x as of June 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.34 Million) by net assets (AU$8.25 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Invion Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Invion Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Invion Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Invion Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Invion Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Invion Ltd from 2006 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$8.25 Million AU$-2.97 Million -0.360x -116.34%
2024-06-30 AU$14.44 Million AU$-2.40 Million -0.166x -68.80%
2023-06-30 AU$18.40 Million AU$-1.81 Million -0.099x -73.98%
2022-06-30 AU$19.58 Million AU$-1.11 Million -0.057x -164.92%
2021-06-30 AU$4.79 Million AU$417.98K 0.087x +410.95%
2020-06-30 AU$5.43 Million AU$-152.47K -0.028x +92.73%
2019-06-30 AU$5.46 Million AU$-2.11 Million -0.386x -531.44%
2018-06-30 AU$7.91 Million AU$707.09K 0.089x +245.01%
2017-06-30 AU$4.01 Million AU$-247.14K -0.062x +90.36%
2016-06-30 AU$5.99 Million AU$-3.83 Million -0.640x +56.67%
2015-06-30 AU$6.86 Million AU$-10.13 Million -1.477x -244.59%
2014-06-30 AU$10.16 Million AU$-4.35 Million -0.429x -36.75%
2013-06-30 AU$11.04 Million AU$-3.46 Million -0.313x +82.26%
2012-06-30 AU$6.01 Million AU$-10.62 Million -1.766x -128.12%
2011-06-30 AU$-2.14 Million AU$-13.46 Million 6.281x +97.36%
2010-06-30 AU$-4.78 Million AU$-15.20 Million 3.182x +4.10%
2008-06-30 AU$-3.23 Million AU$-9.86 Million 3.057x +117.84%
2007-06-30 AU$715.28K AU$-12.26 Million -17.134x -597.95%
2006-06-30 AU$4.83 Million AU$-11.87 Million -2.455x --